Top 15 Biotechnology Angel Investors in Mexico (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Micah Parsons
Angel
|
2 | Mexico | Seed, Angel | Medical, Wellness, Health Care | |
|
Bob Goodman
Angel
|
1 | United States, Israel, Germany | Series B, Series C, Series D | Software, Enterprise Software, SaaS | $10M–$135M |
|
Geoffrey KALISH
Angel
|
1 | United States | Series A | AgTech, Seafood, Biotechnology | |
|
Paul Buchheit
Angel
|
1 | United States, Canada, India | Seed, Series A, Angel | Software, SaaS, Health Care | $100k–$14M |
|
Sohail Prasad
Angel
|
1 | United States, France, Mexico | Seed, Series A | Software, Human Resources, Financial Services | $1.3M–$25M |
|
Matt Cutts
Angel
|
1 | United States, Canada, Mexico | Seed, Angel, Series A | SaaS, Health Care, Medical | $493k–$2.8M |
|
Elizabeth Iorns
Angel
|
1 | United States, Canada, Mexico | Seed, Pre-Seed | Software, SaaS, Health Care | $1.9M–$3M |
|
Ashton Kutcher
Angel
|
1 | United States, Germany, Canada | Seed, Series A, Series B | Software, E-Commerce, FinTech | $800k–$125M |
|
Jessica Livingston
Angel
|
1 | United States, Mexico | Seed, Series A, Angel | Education, Health Care, Medical Device | $600k–$10M |
|
Mark Gormley
Angel
|
1 | United States, Canada | Private Equity, Series A, Secondary Market | Insurance, Risk Management, Service Industry | |
|
Dan Knox
Angel
|
1 | Mexico, United States | Seed, Venture - Series Unknown | Finance, Health Care, Crowdfunding | |
|
Jason Burke
Angel
|
1 | United States, Mexico | Seed, Pre-Seed, Angel | Information Technology, Internet, Software | $1M–$2.9M |
|
Robert Stavis
Angel
|
1 | United States, Canada, Germany | Series A, Series B, Series C | Financial Services, FinTech, Finance | $4.5M–$126M |
|
Eric Urhane
Angel
|
1 | United States, Mexico, Singapore | Seed, Angel | Software, Health Care, Biotechnology | $1.1M–$1.9M |
|
Jeffrey Horing
Angel
|
1 | United States, Israel, Canada | Series B, Series C, Series A | Software, Artificial Intelligence, SaaS | $8.7M–$210M |
| Access all 13 angel investors in Mexico Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Micah Parsons is based out of Irving, Texas, and is the Board Member of RejuvStem. Micah Parsons attended Penn State University.
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Stage:Seed, Angel
- Geography: Mexico
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- RejuvStem — RejuvStem Clinic and Wellness is a specialized healthcare operator dedicated to advancing regenerative medicine through science-based, patient-centered care, the clinic provides cutting-edge recovery treatments, cellular optimization, and personalized longevity protocols. RejuvStem stands out as an authorized partner of DezawaMuse Cells®, offeringelite pluripotent stem cell preparations paired with full-body Cold Atmospheric Plasma (CAP) technology using the German-engineered Human Regenerator Jet.
Robert Goodman is a general partner at Goodman served as a director at he joined Bessemer Venture Partners. He has also worked at Goodman holds a bachelor’s degree in arts from
Show more...Investment focus
- Industry: Software, Enterprise Software, SaaS
- Stage:Series B, Series C, Series D
- Geography: United States, Israel, Germany
Investor stats
- Total investments: 63
- Round size: Series B $10M–$40M; Series C $15M–$57M; Series D $10M–$135M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- cargo.one — The cargo.one booking platform gives you access to real-time prices and available capacities of multiple airlines. Directly book online within seconds, 24/7.
- DriveNets — DriveNets is a leader in large-scale networking solutions for AI infrastructure and service providers, powering production networks for global tier-1 operators
- Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Mr. Kalish is a Partner & Chief Operating Officer at Aquiline Capital Partners.Previously, Mr. Kalish was also the Founder and Managing Director at Venturion Capital. He has served on the boards of numerous financial services companies in Europe and the US. He holds a history degree from Columbia and a masters degree in public policy fromHarvard.
Show more...Investment focus
- Industry: AgTech, Seafood, Biotechnology
- Stage:Series A
- Geography: United States
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Series A, Angel
- Geography: United States, Canada, India
Investor stats
- Total investments: 167
- Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$14M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
- BuildForever — We build products that feel personal, magical and deeply human
- Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Sohail is the Founder & CEO of Destiny (D/XYZ). Sohail is also Founder & former Co-CEO of Forge, the stock market for private companies. He has an extensive background in product management, engineering, and business. As an eighteen-year-old, he was among the youngest founders to go through Y Combinator. Over the years, Sohail has advised and invested in over 100 startups, including notable startups such as Zenefits and Rappi. He continues to invest actively through S2 Capital, and serves as its Founding Partner. Prior to founding Equidate, Sohail managed mobile product at Zynga. He previously joined mobile advertising firm Chartboost as its second engineering hire, and has held roles at Google and the MIT Media Lab. Sohail was awarded TCU's Texas Youth Entrepreneur of the Year award in 2010, and was later named a Thiel Fellow by the Thiel Foundation. He previously attended Carnegie Mellon University where he studied Electrical & Computer Engineering.
Show more...Investment focus
- Industry: Software, Human Resources, Financial Services
- Stage:Seed, Series A
- Geography: United States, France, Mexico
Investor stats
- Total investments: 14
- Round size: Seed $1.3M–$4M; Series A $11M–$25M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- Wethenew — Acquistate le vostre autentiche sneakers prodotti streetwear in edizione limitata in modo sicuro e protetto su wethenew.com!
- Series — Series provides full-stack enterprise financial services designed for institutions & enterprises.
Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his
Show more...Investment focus
- Industry: SaaS, Health Care, Medical
- Stage:Seed, Angel, Series A
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 11
- Round size: Seed $493k–$2.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- X-ZELL — Early, pain-free cancer cell detection
- Meter Feeder — Easily pay for parking through MeterFeeder
Elizabeth Iorns is the Co-Founder, President, and CEO of Science Exchange. She previously worked at Y Combinator as a Part-time partner. Elizabeth Iorns attended the University of Auckland.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 6
- Round size: Seed $1.9M–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Torch — Connect experienced human coaches, Spark AI and your business priorities. Explore coaching for leaders, teams and organizational change with Torch.
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- Enzyme — Enzyme QMS software includes modules for all stages of the product development life cycle from Design Control to CAPA. Our in-house experts are here to back you up! We can guide you through the quality challenges and regulatory submission process. Sign up for a Demo today.
Kutcher is the executive producer for the Netflix series The Ranch. He was previously known for his role in Two and a Half Men on CBS and gained fame on That '70s Show. He co-founded Thorn: Digital Defenders of Children, an organization that uses technology to combat child exploitation. Ashley Kutcher is an actor, investor, entrepreneur, producer, and philanthropist. For over a decade, Kutcher has been involved in technology investments as an angel investor and a founding partner of A-Grade Investments and Sound Ventures. His investment portfolio includes companies like Airbnb, Uber, Flexport, Brex, Robinhood, Bird, Airtable, and Affirm. He co-founded APlus, a digital media company focused on positive journalism, which was acquired by Chicken Soup for the Soul in 2016.
Show more...Investment focus
- Industry: Software, E-Commerce, FinTech
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 142
- Round size: Seed $800k–$7M; Series A $6M–$30M; Series B $12M–$125M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Soho House — Soho House has members' clubs across Europe, North America and Asia, as well as restaurants, cinemas, workspaces, spas and bedrooms. Discover more here.
- Unrivaled — A 3v3 league built in collaboration with the biggest stars in women's basketball, co-founded by Napheesa Collier and Breanna Stewart. Launching in January 2025.
- Arcade — Arcade is a B2C platform that transforms the jewelry market through its prompt-to-product solution, allowing users to create unique designs using AI. The marketplace supports various user roles, enabling customers, designers, and influencers to engage and collaborate.
Jessica Livingston is the Founding Partner of Y Combinator. She is also the organizer of Startup School.
Show more...Investment focus
- Industry: Education, Health Care, Medical Device
- Stage:Seed, Series A, Angel
- Geography: United States, Mexico
Investor stats
- Total investments: 18
- Round size: Seed $600k–$3.3M; Series A $7M–$10M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Elpha — Elpha is where women succeed at work together. Become a member to access daily conversations with experts, insider job opportunities, and a lot of women talking candidly about work and life. Plus membership is free!
- Tesseral — Okapi facilitates the storing, updating, and retrieval of customer data for businesses using CRM (customer relationship management) software.
- Hype and Vice — Hype and Vice combines on-trend fashion with University brands to create officially licensed college apparel women! Cool college apparel to wear for tailgates and gamedays or to lounge around your dorm.
Mark K. Gormley is a Partner at Lee Equity Partners. Prior to joining Lee Equity in 2006, Mr. Gormley was a Partner at Capital Z Financial Services Partners (“CZFS”), a leading financial services private equity firm, where he played a leading role in the operations and investment activities of the $1.85 billion fund. Mr. Gormley co-founded CZFS in1998 and shared responsibility for the oversight of all of the firm's investment and monitoring activities. Prior to founding CZFS, Mr. Gormley served as a Managing Director at Donaldson, Lufkin & Jenrette (“DLJ”), specializing in the insurance and asset management industries. While at DLJ, Mr. Gormley worked on corporate finance and merger and acquisition assignments, as well as on principal related activities on behalf of DLJ Merchant Banking. Prior to joining DLJ in 1989, he was a founding member of the Insurance Group at Merrill Lynch in 1985. Mr. Gormley serves or has served as a director of numerous public and private companies, including The Edelman Financial Group, Skopos Financial Group, Captive Resources, Carlile Bancshares, PDR Network, MidCap Financial, Universal American, Permanent General, NewStar Financial, British Marine Holdings, Catlin Group, Bank Handlowy, Ceska Sporitelna, NACOLAH among others. Mr. Gormley received a B.S.B.A. cum laude in Finance and Economics from the University of Denver and an M.B.A. from New York University.
Show more...Investment focus
- Industry: Insurance, Risk Management, Service Industry
- Stage:Private Equity, Series A, Secondary Market
- Geography: United States, Canada
Investor stats
- Total investments: 5
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
- Axis Insurance — Axis Insurance stands at the forefront of the insurance industry, drawing on decades of expertise and a forward-thinking approach.
- Pure Financial Advisors — Pure Financial Advisors is a fee-only financial planning firm providing retirement planning services and tax-optimized investment management.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Dan Knox is based out of San Francisco, California and is the founder of Unleash Therapeutics. Dan previously worked at DailyMe as a head of operations. Dan Knox attended the MIT - Sloan School of Management.
Show more...Investment focus
- Industry: Finance, Health Care, Crowdfunding
- Stage:Seed, Venture - Series Unknown
- Geography: Mexico, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- Experiment — Experiment is an online community and a crowdfunding platform for scientific research. It provides crowdfunding services for scientific research related to categories such as biology, chemistry, computer science, medicine, anthropology, psychology, engineering, and more.The platform provides its services for researchers from over 150institutions and universities around the world. It is in strategic partnerships with Experiment was founded by
Jason Burke is the Co-founder, Managing Director, and Investor of TBD Angels and the VP of Strategy and Business Development of Xandr. Prior to that, he was the Chief Strategy Officer for clypd, a Boston-based startup building an advertising technology platform exclusively for the TV industry and designed to empower media companies with actionablesales tools. In his role, Burke focuses on a forward-looking platform and business strategy, corporate development, partnerships, and management of clypd's strategic commercial deals.As one of the first employees at clypd, Burke spent over 3 years as VP, Product leading the product & operations teams in bringing innovative products to the $180B television advertising market. Prior to clypd, Burke spent six years building ad technology products for online video at ScanScout and Tremor Video where he had responsibility for product management, technical strategy and operations efforts.Jason is a leader with the unique experience of working with executive customer teams and internal product development/engineering groups to drive business while also solving software and implementation challenges with internal and external technical teams. He is also a frequent contributor to industry publications and participant on advertising technology and media conference presentations and panels. Jason holds several software patents focused on inventions in advertising technology and media.Jason is also an investor in early-stage companies across several verticals. He feels privileged to invest in and collaborate with talented founding teams seeking to change the world with innovative products & businesses.Jason is based in Boston and has degrees in Computer Science and Engineering Psychology from Tufts University.
Show more...Investment focus
- Industry: Information Technology, Internet, Software
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, Mexico
Investor stats
- Total investments: 6
- Round size: Seed $1M–$2.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Eva — Eden unifies medical imaging operations with clinical AI: PACS, teleradiology, AI-assisted diagnosis and structured reporting, deployed across 2,600+ imaging departments.
- Wrangle — Wrangle organizes requests in your Slack team channel. Automatically assign approvals and tasks for your team to follow up and track their status.
- WorkAround — The domain name WAO.ai, a captivating three-letter, one-syllable domain, holds a universe of possibilities within its concise and impactful structure. It effortlessly merges the essence of wonder, awe, and amazement with cutting-edge techno
Robert Michael Stavis is based out of Larchmont, New York and is the Partner of Bessemer Venture Partners. Robert previously worked at 2U as a Board Member. Robert Stavis attended the University of Pennsylvania.
Show more...Investment focus
- Industry: Financial Services, FinTech, Finance
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 53
- Round size: Series A $4.5M–$38M; Series B $9.8M–$126M; Series C $10M–$34M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
- Flower Company — We sell weed on the internet. Thousands of products delivered overnight throughout California from Humboldt to San Diego
- Bespoke Financial — Bespoke Financial is a licensed lender supporting cannabis companies. They alleviate working capital constraints across the entire cannabis supply chain. Bespoke supports their clients as they scale and grow with unique financing solutions and cannabis business loans.
Eric Urhane
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Angel
- Geography: United States, Mexico, Singapore
Investor stats
- Total investments: 5
- Round size: Seed $1.1M–$1.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- X-ZELL — Early, pain-free cancer cell detection
- Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.
Jeffrey Horing is based out of New York, New York and is the Managing Director of Insight Partners. Jeffrey previously worked at E.M. Warburg, Pincus & Co as a Team Member. Jeffrey Horing attended the University of Pennsylvania.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Series B, Series C, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 129
- Round size: Series A $8.7M–$125M; Series B $21M–$115M; Series C $25M–$210M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
- Elio Mortgage — Elio Mortgage LLC is an AI-native mortgage brokerage startup designed to blend human relationships with automated backend support. The company functions as a modern alternative to traditional retail lenders and legacy brokerages.
- Airis Labs — Airis Labs provides a platform that turns user-generated content into field intelligence. The system extracts information from videos, images, audio, and text to help identify threats. It processes large amounts of unstructured data to support investigations and monitoring. The platform reduces time spent reviewing footage by automating theanalysis process. It offers high accuracy in locating urban areas from visual data. Airis combines multiple tools into one system for intelligence gathering and threat mapping. The platform can be deployed on private servers or through cloud networks.
Biotechnology Angel investor funding in Mexico at a glance
Stats across 4 deals from 13 investors.
Access all 13 angel investors in Mexico Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Angel Investors in Mexico investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 13 angel investors investing in Mexico Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!